Clinical Trials Browser

Completed × apatorsen × Genitourinary × Clear all

NCT01780545 2022-07-11

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

Phase 2 Completed

200 enrolled 11 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01120470 2019-02-15

OGX-427 in Castration Resistant Prostate Cancer Patients

Phase 2 Completed

Prostatic Neoplasms